Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

FDA accepts Vitrase NDA for filing

Oct. 10, 2003

Novartis presents new IOP-lowering agents in recent patent

Oct. 10, 2003

Improved vision observed in phase I/II trial of squalamine in wet AMD

Oct. 9, 2003

Integrin antagonists useful for angiogenesis-related ocular diseases

Sep. 30, 2003

FDA accepts for filing diquafosol NDA for dry eye

Sep. 15, 2003

EntreMed grants Oxford BioMedica gene rights for ophthalmic applications

Sep. 12, 2003

Good efficacy and safety profile described for ranibizumab in AMD

Sep. 3, 2003

Intravitreous hyaluronidase effective in reducing vitreous hemorrhage density

Sep. 3, 2003

VEGF Trap prevents blinding blood vessel growth in mice

Aug. 28, 2003

Improved vision in extension phase of Lucentis wet AMD study

Aug. 27, 2003

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...